Naganawa M - Search Results

1

PET Imaging of Pancreatic Dopamine D₂ and D₃ Receptor Density with ¹¹C-(+)-PHNO in Type 1 Diabetes.

Bini J, Sanchez-Rangel E, Gallezot JD, Naganawa M, Nabulsi N, Lim K, Najafzadeh S, Shirali A, Ropchan J, Matuskey D, Huang Y, Herold KC, Harris PE, Sherwin RS, Carson RE, Cline GW. Bini J, et al. Among authors: naganawa m. J Nucl Med. 2020 Apr;61(4):570-576. doi: 10.2967/jnumed.119.234013. Epub 2019 Oct 10. J Nucl Med. 2020. PMID: 31601695 Free PMC article.

2

A feasibility study of [11C]SA4503-PET for evaluating sigmal receptor occupancy by neuroleptics: the binding of haloperidol to sigma1 and dopamine D2-like receptors.

Ishiwata K, Oda K, Sakata M, Kimura Y, Kawamura K, Oda K, Sasaki T, Naganawa M, Chihara K, Okubo Y, Ishii K. Ishiwata K, et al. Among authors: naganawa m. Ann Nucl Med. 2006 Oct;20(8):569-73. doi: 10.1007/BF03026824. Ann Nucl Med. 2006. PMID: 17134027

3

Tracer kinetic modeling of [(11)C]AFM, a new PET imaging agent for the serotonin transporter.

Naganawa M, Nabulsi N, Planeta B, Gallezot JD, Lin SF, Najafzadeh S, Williams W, Ropchan J, Labaree D, Neumeister A, Huang Y, Carson RE. Naganawa M, et al. J Cereb Blood Flow Metab. 2013 Dec;33(12):1886-96. doi: 10.1038/jcbfm.2013.134. Epub 2013 Aug 7. J Cereb Blood Flow Metab. 2013. PMID: 23921898 Free PMC article.

4

Clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: Implications on treatment of depression and ADHD.

Ding YS, Naganawa M, Gallezot JD, Nabulsi N, Lin SF, Ropchan J, Weinzimmer D, McCarthy TJ, Carson RE, Huang Y, Laruelle M. Ding YS, et al. Among authors: naganawa m. Neuroimage. 2014 Feb 1;86:164-71. doi: 10.1016/j.neuroimage.2013.08.001. Epub 2013 Aug 9. Neuroimage. 2014. PMID: 23933039

5

Event-by-event respiratory motion correction for PET with 3D internal-1D external motion correlation.

Chan C, Jin X, Fung EK, Naganawa M, Mulnix T, Carson RE, Liu C. Chan C, et al. Among authors: naganawa m. Med Phys. 2013 Nov;40(11):112507. doi: 10.1118/1.4826165. Med Phys. 2013. PMID: 24320466

6

Evaluation of the agonist PET radioligand [¹¹C]GR103545 to image kappa opioid receptor in humans: kinetic model selection, test-retest reproducibility and receptor occupancy by the antagonist PF-04455242.

Naganawa M, Jacobsen LK, Zheng MQ, Lin SF, Banerjee A, Byon W, Weinzimmer D, Tomasi G, Nabulsi N, Grimwood S, Badura LL, Carson RE, McCarthy TJ, Huang Y. Naganawa M, et al. Neuroimage. 2014 Oct 1;99:69-79. doi: 10.1016/j.neuroimage.2014.05.033. Epub 2014 May 17. Neuroimage. 2014. PMID: 24844744 Free PMC article.

7

Kinetic modeling of (11)C-LY2795050, a novel antagonist radiotracer for PET imaging of the kappa opioid receptor in humans.

Naganawa M, Zheng MQ, Nabulsi N, Tomasi G, Henry S, Lin SF, Ropchan J, Labaree D, Tauscher J, Neumeister A, Carson RE, Huang Y. Naganawa M, et al. J Cereb Blood Flow Metab. 2014 Nov;34(11):1818-25. doi: 10.1038/jcbfm.2014.150. Epub 2014 Sep 3. J Cereb Blood Flow Metab. 2014. PMID: 25182664 Free PMC article. Clinical Trial.

8

Association of in vivo κ-opioid receptor availability and the transdiagnostic dimensional expression of trauma-related psychopathology.

Pietrzak RH, Naganawa M, Huang Y, Corsi-Travali S, Zheng MQ, Stein MB, Henry S, Lim K, Ropchan J, Lin SF, Carson RE, Neumeister A. Pietrzak RH, et al. Among authors: naganawa m. JAMA Psychiatry. 2014 Nov;71(11):1262-1271. doi: 10.1001/jamapsychiatry.2014.1221. JAMA Psychiatry. 2014. PMID: 25229257 Retracted.

9

Test-retest reproducibility of binding parameters in humans with 11C-LY2795050, an antagonist PET radiotracer for the κ opioid receptor.

Naganawa M, Zheng MQ, Henry S, Nabulsi N, Lin SF, Ropchan J, Labaree D, Najafzadeh S, Kapinos M, Tauscher J, Neumeister A, Carson RE, Huang Y. Naganawa M, et al. J Nucl Med. 2015 Feb;56(2):243-8. doi: 10.2967/jnumed.114.147975. Epub 2015 Jan 15. J Nucl Med. 2015. PMID: 25593119 Free PMC article.

10

Receptor Occupancy of the κ-Opioid Antagonist LY2456302 Measured with Positron Emission Tomography and the Novel Radiotracer 11C-LY2795050.

Naganawa M, Dickinson GL, Zheng MQ, Henry S, Vandenhende F, Witcher J, Bell R, Nabulsi N, Lin SF, Ropchan J, Neumeister A, Ranganathan M, Tauscher J, Huang Y, Carson RE. Naganawa M, et al. J Pharmacol Exp Ther. 2016 Feb;356(2):260-6. doi: 10.1124/jpet.115.229278. Epub 2015 Dec 1. J Pharmacol Exp Ther. 2016. PMID: 26628406 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

100 results

Search Page